Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Vemlidy
(United States) [Available]Synonyms :
Tenofovir alafenamide
Class :
Antiviral agents and Anti-HBV (Reverse Transcriptase Inhibitors
Brand Name :
Vemlidy
(United States) [Available]Synonyms :
Tenofovir alafenamide
Class :
Antiviral agents and Anti-HBV (Reverse Transcriptase Inhibitors
Dosage Forms & StrengthsÂ
Tablet, Oral:Â
25 mg Â
Note: Discontinuation of tenofovir alafenamide for hepatitis B therapy, can result in severe acute exacerbations of hepatitis B.Â
No safe and efficacious dose describedÂ
Refer to adult dosingÂ
may have an increased nephrotoxic effect when combined with tenofovir products
may have an increased nephrotoxic effect when combined with tenofovir products
may have an increased nephrotoxic effect when combined with tenofovir products
may have an increased nephrotoxic effect when combined with tenofovir products
may have an increased nephrotoxic effect when combined with tenofovir products
the serum levels of tenofovir alafenamide may be increased when administered with oxybenzone
Ritonavir may reduce the therapeutic effects of Tenofovir alafenamide, avoid a combination
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
tenofovir alafenamide: they may diminish the serum concentration of rifabutin
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
may increase the risk of adverse effect of other reverse transcriptase inhibitors
reverse transcriptase inhibitors increase the concentration of ergonovine in the serum
May increase plasma concentration and therapeutic effects of other antiretroviral drugs
May increase plasma concentration and therapeutic effects of other antiretroviral drugs
Tenofovir alafenamide increases the serum concentrations of pantoprazole, dose adjustments may be suggested to avoid toxicity
May enhance the therapeutic concentration of Tenofovir alafenamide
Coadministration of Tenofovir alafenamide with warfarin can increase the risk of bleeding or unusual bleeding
may enhance the serum concentration when combined with ganciclovir-valganciclovir
It may enhance the effect when combined with tafamidis meglumine
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
may decrease the level of serum concentration
when chloroxylenol is combined with tenofovir alafenamide, the serum concentration of tenofovir alafenamide may be elevated
the serum concentration if tenofovir alafenamide may be in creased
Frequency defined:Â Â Â
>10%:Â
HeadacheÂ
Decreased bone mineral density Â
1% to 10%:Â
Skin rashÂ
Increased serum creatine kinaseÂ
Abdominal painÂ
DiarrheaÂ
DyspepsiaÂ
Flatulence Â
NauseaÂ
Vomiting Â
Fatigue Â
Arthralgia Â
Back painÂ
Cough  Â
Frequency not defined:Â
Exacerbation of hepatitis BÂ
Â
Pregnancy consideration: Tenofovir alafenamide can transfer in minor amounts across the human placenta. Â
Lactation: Tenofovir alafenamide excretion in breast milk is not known. Â
Pregnancy category:Â
Â
Patient information leafletÂ
Generic Name: Tenofovir alafenamide Â
Pronunciation: Tenofovir alafenamide Â
Why do we use Tenofovir alafenamide?Â
It is used to treat viral infections such as Hepatitis B infection.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
